Literature DB >> 16183295

Synthesis, cytotoxicity, and DNA-topoisomerase inhibitory activity of new asymmetric ureas and thioureas.

Andressa Esteves-Souza1, Kenia Pissinate, Maria da Graça Nascimento, Noema Faiga Grynberg, Aurea Echevarria.   

Abstract

A new series of N-3,3-diphenylpropyl-N-(p-X-benzyl)-N'-phenylureas (5a-g) and thioureas (6a-g) were synthesized by the reaction of secondary amines and phenyl isocyanate or isothiocyanate. The cytotoxic effects of the urea and thiourea derivatives were evaluated by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay against Ehrlich carcinoma and K562 human leukemia cells. Moreover, the activity of compounds in the inhibition of DNA topoisomerases I and II-alpha was tested. The results indicated that the compounds presented important and promising antiproliferative action.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183295     DOI: 10.1016/j.bmc.2005.08.031

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Design, synthesis and anticancer activity of some novel thioureido-benzenesulfonamides incorporated biologically active moieties.

Authors:  Mostafa M Ghorab; Mansour S Alsaid; Mohamed S Al-Dosary; Yassin M Nissan; Sabry M Attia
Journal:  Chem Cent J       Date:  2016-04-07       Impact factor: 4.215

2.  Synthesis and Antitumor Activities of Chiral Dipeptide Thioureas Containing an Alpha-Aminophosphonate Moiety.

Authors:  Jingzi Liu; Peng Liao; Junfeng Hu; Hong Zhu; Yonglin Wang; Yongjun Li; Yan Li; Bin He
Journal:  Molecules       Date:  2017-02-16       Impact factor: 4.411

3.  Solvent-free synthesis, DNA-topoisomerase II activity and molecular docking study of new asymmetrically N,N'-substituted ureas.

Authors:  Andressa Esteves-Souza; Claudio E Rodrigues-Santos; Catarina de Nigris Del Cistia; Daniel Rosa da Silva; Carlos Maurício R Sant'anna; Aurea Echevarria
Journal:  Molecules       Date:  2012-11-01       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.